References
- Cottin V, Plauchu H, Bayle JY, Barthelet M, Revel D, Cordier JF. Pulmonary arteriovenous malformations in patients with hereditary hemorrhagic telangiectasia. Am J Respir Crit Care Med 2004;169:994–1000.
- Govani F, Shovlin C. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet 2009;17:860–71.
- Faughnan ME, Palda VA, Garcia-Tsao G. International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. J Med Genet 2011;48:73–87.
- Rebeiz EE, Park S, Shapshay SM. Treatment of hereditary hemorrhagic telangiectasia with Neodymium: Yttrium-Aluminum-Garnet laser photocoagulation. Oper Tech Otolaryngol Head Neck Surg 1991;2:177–82.
- Bergler W, Sadick H, Gotte K, Riedel F, Hormann K. Topical estrogens combined with argon plasma coagulation in the management of epistaxis in hereditary hemorrhagic telangiectasia. Ann Otol Rhinol Laryngol 2002;111:222–8.
- Al-Deen S, Bachmann-Harildstad G. A grading scale for epistaxis in hereditary haemorrhagic teleangectasia. Rhinology 2008;46:281–4.
- Hoag J, Terry P, Mitchell S, Reh D, Merlo C. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope 2010;120:838–43.
- Geisthoff U, Fiorella M, Fiorella R. Treatment of recurrent epistaxis in HHT. Curr Pharm Des 2006;12:1237–42.
- Lund V, Howard D. A treatment algorithm for the management of epistaxis in hereditary hemorrhagic telangiectasia. Am J Rhinol 1999;13:319–22.
- Lund V, Howard D. Closure of the nasal cavities in the treatment of refractory hereditary haemorrhagic telangiectasia. J Laryngol Otol 1997;111:30–3.
- Gluckman J, Portugal L. Modified Young's procedure for refractory epistaxis due to hereditary hemorrhagic telangiectasia. Laryngoscope 1994;104:1174–7.
- Hosni A, Innes A. Hereditary haemorrhagic telangiectasia: Young's procedure in the management of epistaxis. J Laryngol Otol 1994;108:754–7.
- Serrano E, Percodani J, Pessey J. Bilateral closure of the nasal cavity. An original surgical technique of treatment of severe recurrent epistaxis in Rendu-Osler disease. Ann Otolaryngol Chir Cervicofac 1998;115:169–73.
- Lesnik GT, Ross DA, Henderson KJ, Joe JK, Leder SB, White RI Jr. Septectomy and septal dermoplasty for the treatment of severe transfusion-dependent epistaxis in patients with hereditary hemorrhagic telangiectasia and septal perforation. Am J Rhinol 2007;21:312–15.
- Pagella F, Colombo A, Matti E. Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients. Am J Rhinol Allergy 2009;23:52–8.
- Pagella F, Semino L, Olivieri C. Treatment of epistaxis in hereditary hemorrhagic telangiectasia patients by argon plasma coagulation with local anesthesia. Am J Rhinol 2006;20:421–5.
- Bergler W, Riedel F, Baker-Schreyer A, Juncker C, Hormann K. Argon plasma coagulation for the treatment of hereditary hemorrhagic telangiectasia. Laryngoscope 1999;109:15–20.
- Ben-Bassat M, Kaplan I, Levy R. Treatment of hereditary haemorrhagic telangiectasia of the nasal mucosa with the carbon dioxide laser. Br J Plast Surg 1978;31:157–8.
- Levine H. Endoscopy and the KTP/532 laser for nasal sinus disease. Ann Otol Rhinol Laryngol 1989;98:46–51.